392 related articles for article (PubMed ID: 35370907)
1. Aberrant Cerebral Iron Trafficking Co-morbid With Chronic Inflammation: Molecular Mechanisms and Pharmacologic Intervention.
Rosenblum SL; Kosman DJ
Front Neurol; 2022; 13():855751. PubMed ID: 35370907
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Iron Deposition in Neurodegeneration.
Dusek P; Hofer T; Alexander J; Roos PM; Aaseth JO
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625641
[TBL] [Abstract][Full Text] [Related]
4. Ageing, neuroinflammation and neurodegeneration.
Ward RJ; Dexter DT; Crichton RR
Front Biosci (Schol Ed); 2015 Jun; 7(1):189-204. PubMed ID: 25961695
[TBL] [Abstract][Full Text] [Related]
5. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells.
Urrutia P; Aguirre P; Esparza A; Tapia V; Mena NP; Arredondo M; González-Billault C; Núñez MT
J Neurochem; 2013 Aug; 126(4):541-9. PubMed ID: 23506423
[TBL] [Abstract][Full Text] [Related]
6. Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.
Anzovino A; Lane DJ; Huang ML; Richardson DR
Br J Pharmacol; 2014 Apr; 171(8):2174-90. PubMed ID: 24138602
[TBL] [Abstract][Full Text] [Related]
7. Diagnostics and Treatments of Iron-Related CNS Diseases.
Xiong H; Tuo QZ; Guo YJ; Lei P
Adv Exp Med Biol; 2019; 1173():179-194. PubMed ID: 31456211
[TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative diseases and therapeutic strategies using iron chelators.
Ward RJ; Dexter DT; Crichton RR
J Trace Elem Med Biol; 2015; 31():267-73. PubMed ID: 25716300
[TBL] [Abstract][Full Text] [Related]
9. The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
Bailey DK; Clark W; Kosman DJ
PLoS One; 2021; 16(7):e0254794. PubMed ID: 34310628
[TBL] [Abstract][Full Text] [Related]
10. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
Daulatzai MA
J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
[TBL] [Abstract][Full Text] [Related]
11. Inflaming the Brain with Iron.
Urrutia PJ; Bórquez DA; Núñez MT
Antioxidants (Basel); 2021 Jan; 10(1):. PubMed ID: 33419006
[TBL] [Abstract][Full Text] [Related]
12. Hereditary causes of disturbed iron homeostasis in the central nervous system.
Ponka P
Ann N Y Acad Sci; 2004 Mar; 1012():267-81. PubMed ID: 15105272
[TBL] [Abstract][Full Text] [Related]
13. Iron chelation in the treatment of neurodegenerative diseases.
Dusek P; Schneider SA; Aaseth J
J Trace Elem Med Biol; 2016 Dec; 38():81-92. PubMed ID: 27033472
[TBL] [Abstract][Full Text] [Related]
14. Review: iron metabolism and the role of iron in neurodegenerative disorders.
Hadzhieva M; Kirches E; Mawrin C
Neuropathol Appl Neurobiol; 2014 Apr; 40(3):240-57. PubMed ID: 24164678
[TBL] [Abstract][Full Text] [Related]
15. The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders.
Urrutia PJ; Mena NP; Núñez MT
Front Pharmacol; 2014; 5():38. PubMed ID: 24653700
[TBL] [Abstract][Full Text] [Related]
16. Molecular Defects in Friedreich's Ataxia: Convergence of Oxidative Stress and Cytoskeletal Abnormalities.
Smith FM; Kosman DJ
Front Mol Biosci; 2020; 7():569293. PubMed ID: 33263002
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and regulation of iron trafficking across the capillary endothelial cells of the blood-brain barrier.
McCarthy RC; Kosman DJ
Front Mol Neurosci; 2015; 8():31. PubMed ID: 26236187
[TBL] [Abstract][Full Text] [Related]
19. The role of zinc, copper, manganese and iron in neurodegenerative diseases.
Mezzaroba L; Alfieri DF; Colado Simão AN; Vissoci Reiche EM
Neurotoxicology; 2019 Sep; 74():230-241. PubMed ID: 31377220
[TBL] [Abstract][Full Text] [Related]
20. Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy.
Visanji NP; Collingwood JF; Finnegan ME; Tandon A; House E; Hazrati LN
J Parkinsons Dis; 2013; 3(4):523-37. PubMed ID: 24113558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
